Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Eales disease (ED) is an idiopathic, inflammatory retinal venous occlusive disease characterized by 3 stages: vasculitis, occlusion and retinal neovascularization, leading to recurrent vitreous hemorrhages and vision loss.
Biomarker and diagnostic research for Eales disease has been reported in the published literature.
Estimated prevalence: Unknown (Unknown prevalence).
No clinical trials have been registered for Eales disease.
26 publications have been identified in PubMed for Eales disease. Research spans Case Report / Case Series (60%), Review / Meta-Analysis (20%), and Diagnostic / Biomarker (8%).
Research Type | Count | % of Total |
|---|---|---|
Patient case studies | 15 | 60% |
Data assembled from 3 of 12 sources · Last updated Sep 19, 2026, 6:35 AM UTC
European rare disease database
Genetic and Rare Diseases Info Center
Common questions about Eales disease
5 |
20% |
Testing and diagnosis research | 2 | 8% |
Clinical study results | 2 | 8% |
Disease patterns and progression | 1 | 4% |
Biswas J (2026). [PMID: 42200728](https://pubmed.ncbi.nlm.nih.gov/42200728/). *Indian J Ophthalmol*. [Diagnostic / Biomarker]
Cifuentes-González C (2026). [PMID: 40972796](https://pubmed.ncbi.nlm.nih.gov/40972796/). *Surv Ophthalmol*. [Review / Meta-Analysis]
Saboya-Galindo P (2026). [PMID: 40983164](https://pubmed.ncbi.nlm.nih.gov/40983164/). *Surv Ophthalmol*. [Review / Meta-Analysis]
Ferreira BFA (2026). [PMID: 39514803](https://pubmed.ncbi.nlm.nih.gov/39514803/). *Retin Cases Brief Rep*. [Case Report / Case Series]
Qadan AB (2026). [PMID: 41776439](https://pubmed.ncbi.nlm.nih.gov/41776439/). *BMC Ophthalmol*. [Case Report / Case Series]
Pramil V (2026). [PMID: 41701339](https://pubmed.ncbi.nlm.nih.gov/41701339/). *Retina*. [Case Report / Case Series]
Papart S (2026). [PMID: 41893867](https://pubmed.ncbi.nlm.nih.gov/41893867/). *Retin Cases Brief Rep*. [Case Report / Case Series]
Majumder PD (2026). [PMID: 41687078](https://pubmed.ncbi.nlm.nih.gov/41687078/). *Retin Cases Brief Rep*. [Case Report / Case Series]
Ambasta A (2026). [PMID: 42097133](https://pubmed.ncbi.nlm.nih.gov/42097133/). *Am J Trop Med Hyg*. [Case Report / Case Series]
Cozzupoli GM (2026). [PMID: 42125777](https://pubmed.ncbi.nlm.nih.gov/42125777/). *Ophthalmic Genet*. [Case Report / Case Series]